Oric Pharmaceuticals, Inc. ORIC Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oric Pharmaceuticals, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oric Pharmaceuticals, Inc.'s accounts payable?
- Oric Pharmaceuticals, Inc. (ORIC) reported accounts payable of $2.9M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s accounts payable changed year-over-year?
- Oric Pharmaceuticals, Inc.'s accounts payable decreased by 43.9% year-over-year, from $5.16M to $2.9M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Oric Pharmaceuticals, Inc.'s accounts payable has grown at a 38.3% compound annual growth rate (CAGR), from $757K to $3.82M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.